Alibaba Health Information Technology Ltd
HKEX:241
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.62
6.15
|
| Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Alibaba Health Information Technology Ltd
Cash & Cash Equivalents
Alibaba Health Information Technology Ltd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Alibaba Health Information Technology Ltd
HKEX:241
|
Cash & Cash Equivalents
¥3.2B
|
CAGR 3-Years
-34%
|
CAGR 5-Years
4%
|
CAGR 10-Years
10%
|
|
|
China Ruyi Holdings Ltd
HKEX:136
|
Cash & Cash Equivalents
¥2.8B
|
CAGR 3-Years
67%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
Cybernaut International Holdings Co Ltd
HKEX:1020
|
Cash & Cash Equivalents
¥51.6m
|
CAGR 3-Years
13%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-15%
|
|
|
Y
|
YesAsia Holdings Ltd
HKEX:2209
|
Cash & Cash Equivalents
$25.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
Hong Kong Technology Venture Co Ltd
HKEX:1137
|
Cash & Cash Equivalents
HK$585.4m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
57%
|
CAGR 10-Years
N/A
|
|
|
Y
|
Yoho Group Holdings Ltd
HKEX:2347
|
Cash & Cash Equivalents
HK$126.3m
|
CAGR 3-Years
49%
|
CAGR 5-Years
67%
|
CAGR 10-Years
N/A
|
|
Alibaba Health Information Technology Ltd
Glance View
Alibaba Health Information Technology Ltd., often referred to as Alibaba Health, is a pioneering force in the rapidly evolving realm of digital healthcare. As the healthcare arm of the Alibaba conglomerate, it capitalizes on the group's formidable tech expertise and e-commerce prowess to streamline health services. Its operations stretch across several domains, from pharmaceutical retail to medical services. One of the company's key strengths lies in its online pharmacy platform. Partnering with various pharmaceutical brands, Alibaba Health provides an extensive digital marketplace for medications, health supplements, and medical devices. This platform not only simplifies access for consumers but also integrates data analytics to manage supply chains efficiently, ensuring timely availability of products. Beyond its e-commerce foundation, Alibaba Health is also cultivating a robust digital health ecosystem. It offers telemedicine services where users can consult healthcare professionals via online platforms, a feature that gained significant traction during pandemic-related lockdowns. Moreover, the company dives deep into health management technologies, utilizing artificial intelligence to develop personalized health plans and digital tools for patient monitoring. By harnessing big data, Alibaba Health assists in forming public health decisions and improving patient outcomes. Revenues stream from not just product sales, but also subscription fees and partnerships with health providers and governments alike, positioning the company as a pivotal player in China's push towards a more integrated and efficient healthcare system.
See Also
What is Alibaba Health Information Technology Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
3.2B
CNY
Based on the financial report for Sep 30, 2024, Alibaba Health Information Technology Ltd's Cash & Cash Equivalents amounts to 3.2B CNY.
What is Alibaba Health Information Technology Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
10%
Over the last year, the Cash & Cash Equivalents growth was -66%. The average annual Cash & Cash Equivalents growth rates for Alibaba Health Information Technology Ltd have been -34% over the past three years , 4% over the past five years , and 10% over the past ten years .
You don't have any saved screeners yet
